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Abstract: Japanese post-fermented teas are produced by a combination of aerobic and 13 
anaerobic microbial fermentation of the leaves of tea plant. Recently, we revealed that 14 
tea products contain characteristic polyphenols identical to the tea catechin metabolites 15 
produced by mammalian intestinal bacteria, such as 16 
(2S)-1-(3',4',5'-trihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol (EGC-M1). 17 
In the present study, degradation of epigallocatechin-3-O-gallate (EGCg) and 18 
epigallocatechin (EGC) with acetone powder prepared from Japanese post-fermented 19 
tea was examined. Under aerobic conditions, EGCg was hydrolyzed to EGC and gallic 20 
acid, which were further converted to gallocatechin (GC) and pyrogallol, respectively. 21 
Under anaerobic conditions, EGCg was hydrolyzed to EGC, which was further 22 
metabolized to GC, EGC-M1 and (4R)-5-(3,4,5-trihydroxyphenyl)-4-hydroxypentanoic 23 
acid (EGC-M2). Gallic acid was degraded to pyrogallol and then further decomposed. 24 
Anaerobic treatment of EGC with the acetone powder yielded EGC-M1, EGC-M2, 25 
(4R)-5-(3,4,5-trihydroxyphenyl)-γ-valerolactone, and (4R)-5-(3,4 26 
-dihydroxyphenyl)-γ-valerolactone. Furthermore, similar anaerobic treatment of rutin 27 
and hesperidin yielded 3,4-dihydroxyphenylacetic acid and 28 
3-(3,4-dihydroxyphenyl)propanoic acid, respectively. 29 
 30 
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1. Introduction 34 
Teas are produced from the leaves of Camellia sinensis (L.) O. Kuntze (Theaceae), and 35 
are generally classified by their manufacturing process into four categories: 36 
unfermented (green), fermented (black), semi-fermented (oolong) and post-fermented 37 
(dark tea, ripe Pu-erh tea, and related products). Black and oolong tea production 38 
includes a process called “tea fermentation”, in which constituents of fresh tea leaves 39 
are chemically altered by enzymes originally contained in the leaves (Roberts, 1962; 40 
Tanaka, Matsuo, & Kouno, 2010). In contrast, the post-fermented teas (PFT) are 41 
produced by aerobic or anaerobic microbial fermentation of heat-processed green tea 42 
leaves (Gong, Watanabe, Yagi, Etoh, Sakata, Ina, & Liu, 1993; Okada, Takahashi, Ohara, 43 
Uchimura, & Kozaki, 1996b). In a previous study, we looked at the chemical 44 
constituents of Chinese PFT produced by aerobic microbial fermentation of green tea, 45 
and demonstrated that the major characteristic constituents are polymeric polyphenols 46 
derived from tea catechins (Jiang, Shii, Matsuo, Tanaka, Jiang, & Kouno, 2011). On the 47 
other hand, Japanese PFT produced by anaerobic microbial fermentation of green tea 48 
contains (2S)-1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol 49 
(EC-M), and 50 
(2S)-1-(3',4',5'-trihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol (EGC-M1), 51 
which are identical to the tea catechin metabolites formed by mammalian intestinal 52 
bacteria (Takagaki & Nanjo, 2010; Wang, Meselhy, Li, Nakamura, Min, Qin, & Hattori, 53 
2001; Meselhy, Nakamura, & Hattori, 1997; Tanaka, Nagai, Shii, Matsuo, & Kouno, 54 
2011). Japanese PFT is mainly produced in Tokushima, Kochi and Ehime prefectures in 55 
the Shikoku region. The PFT in Tokushima prefecture is produced by anaerobic 56 
fermentation of green tea, and it was demonstrated that Lactobacillus plantarum and 57 
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Klebsiella pneumoniae are the dominant microorganisms involved in the fermentation 58 
(Okada, Takahashi, Ohara, Uchimura, & Kozaki, 1996a). The PFT products in Kochi 59 
and Ehime prefectures are produced by both aerobic and anaerobic fermentation 60 
processes, and many aerobic fungi and anaerobic bacteria have been identified (Tamura, 61 
Kato, Omori, Nanba, & Miyagawa, 1994). The HPLC profiles of these two types of 62 
Japanese PFT are quite different: Tokushima-type contains catechin galloyl esters along 63 
with the tea catechin metabolites. In the Ehime and Kochi-type, the galloyl esters are 64 
completely hydrolyzed, and the resulting gallic acid is further converted to pyrogallol 65 
(Tanaka et al., 2011). The aims of this study were 1) to confirm the constituents of PFT 66 
produced in Ehime-prefecture, and 2) to examine degradation of tea catechins and 67 
flavonoids by treatment with an acetone powder prepared from the PFT. 68 
 69 
2. Materials and methods 70 
2.1. Materials 71 
The PFT produced in Ehime prefecture, Japan, was purchased in October, 2010. 72 
Standard samples of tea catechins were separated from green tea and purified by 73 
crystallization from water. (2S)-1-(3',4'- 74 
Dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol and (2S)-1-(3',4',5'- 75 
trihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol were isolated from PFT 76 
produced in Tokushima prefecture, Japan (Tanaka et al., 2011). 77 
 78 
2.2. Analytical Procedures 79 
UV spectra were obtained using a JASCO V-560 UV/VIS spectrophotometer 80 
(Jasco Co., Tokyo, Japan). 1H and 13C NMR spectra were recorded in acetone-d6 + D2O 81 
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(9:1, v/v), CD3OD, or DMSO-d6 at 27°C with a JEOL JNM-AL400 spectrometer (JEOL 82 
Ltd., Tokyo, Japan) operating at a 1H frequency of 400 MHz. Coupling constants are 83 
expressed in Hz and chemical shifts are presented on a δ (ppm) scale. Column 84 
chromatography was performed using Sephadex LH-20 (25−100 μm, GE Healthcare 85 
Bio-Science AB, Uppsala), Diaion HP20SS (Mitsubishi Chemical, Japan), MCI gel 86 
CHP 20P (75–150 µm; Mitsubishi Chemical, Tokyo, Japan) and Chromatorex ODS 87 
(100–200 mesh; Fuji Silysia Chemical, Kasugai, Japan) columns. Thin layer 88 
chromatography was performed on precoated Kieselgel 60 F254 plates (0.2 mm thick, 89 
Merck KGaA, Darmstadt, Germany) with toluene-ethyl formate-formic acid (1:7:1, v/v) 90 
and CHCl3-MeOH-water (14:6:1, v/v). Spots were detected using ultraviolet (UV) 91 
illumination and by spraying with 2% ethanolic FeCl3 or a 10% sulfuric acid reagent 92 
followed by heating. Analytical HPLC was performed using a Cosmosil 5C18-AR II 93 
(Nacalai Tesque Inc., Kyoto, Japan) column (4.6 mm i.d. × 250 mm) with gradient 94 
elution from 4–30% (39 min) and 30–75% (15 min) of CH3CN in 50 mM H3PO4; the 95 
flow rate was 0.8 mL/min, and detection was achieved using a Jasco photodiode array 96 
detector MD-910. 97 
 98 
2.3. Extraction and separation 99 
PFT (64 g) was pulverized using a blender and extracted with 60% acetone in 100 
H2O (2 L) at rt for 18 h. After filtration, the filtrate was concentrated until acetone was 101 
completely removed. The resulting precipitates were removed by filtration, and the 102 
filtrate was fractionated by Diaion HP20SS column chromatography (5 cm i.d. × 25 cm) 103 
with water containing increasing proportions of MeOH (0 – 100%, 10% stepwise, each 104 
300 ml) to give 11 fractions: Fr. 1 (7.2 g), Fr. 2 (0.6 g), Fr. 3 (0.9 g), Fr. 4 (1.6 g), Fr. 5 105 
6 
 
(3.0 g), Fr. 6 (0.5 g), Fr. 7 (0.8 g), Fr. 8 (1.6 g), Fr. 9 (1.8 g), and Fr. 10 (6.3 g). A portion 106 
(0.57 g) of Fr. 1 was separated by silica gel with CHCl3-MeOH-H2O, 40:10:1 and then 107 
14:6:1, (v/v) to give lactic acid (107 mg). Fr. 2 and 3 were identified to be gallic acid 108 
and pyrogallol, respectively, by comparison of 1H NMR data and HPLC retention time 109 
with those of authentic samples. Fr. 4 was separated by Sephadex LH-20 column 110 
chromatography (3 cm i.d. × 20 cm) with EtOH to give (-)-gallocatechin (619 mg) as 111 
colorless needles from H2O, [α]D22 +0.03 (c = 1.0, acetone), and pyrogallol (130 mg). Fr. 112 
5 was found to be a mixture of (-)-epigallocatechin and 113 
(2S)-1-(3',4',5'-trihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol by HPLC 114 
and TLC comparison with the authentic samples. Fr. 6 was applied to a Sephadex 115 
LH-20 column (3 cm i.d. × 16 cm) with 60% MeOH to yield 116 
catechin-(4α→8)-epigallocatechin (41 mg). Fr. 7 was subjected to Sephadex LH-20 117 
column chromatography (3 cm i.d. × 20 cm) with EtOH to give 3-O-methylgallic acid 118 
(43 mg) and (-)-catechin (146 mg) as colorless needles from H2O, [α]D -6.59 (c 1.0, 119 
acetone). HPLC analysis of Fr. 8 revealed the presence of (-)-epicatechin and 120 
(2S)-1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol. Fr. 9 was 121 
subjected to Sephadex LH-20 column chromatography (3 cm i.d. × 20 cm) with EtOH 122 
to give 3-O-methyl pyrogallol (12.4 mg), (-)-epigallocatechin-3-O-gallate (85 mg) and 123 
dihydromyricetin (8.6 mg). HPLC analysis showed that Fr. 10 contained caffeine, 124 
quercetin, and kaempferol. 125 
 126 
2.4. Determination of absolute configuration of lactic acid 127 
Lactic acid (20 mg) isolated from the PFT was dissolved in MeOH (1.0 mL) 128 
and treated with an ether solution of diazomethane in an ice bath for 30 min. After 129 
7 
 
removal of solvent and excess reagent by evaporation, the residue was dissolved in 130 
pyridine (0.5 mL) containing 4-methoxybenzoyl chloride (50 mg) at rt for 2 h. The 131 
reaction mixture was partitioned between H2O and diethyl ether, and the organic layer 132 
was dried over Na2SO4. After filtration, the filtrate was concentrated and subjected to 133 
silica gel chromatography with hexane-acetone (9:1, v/v) to give methyl 134 
2-(4-methoxybenzoyl)-lactate (2 mg). The product was analyzed by CHIRALCEL 135 
OJ-RH (4.6 mm × 150 mm, Daicel Chemical Industries, Ltd.) with 40% CH3CN in 100 136 
mM KPF6 (pH 2), at 35°C, flow rate 0.8 mL/min. Retention times of the derivatives of 137 
D- and L-lactic acid was obtained using the derivatives prepared from racemic methyl 138 
lactate and L-methyl lactate in a similar manner (L-derivative: 11.6 min, D-derivative: 139 
13.6 min). 140 
 141 
2.5. Determination of absolute configuration of gallocatechin. 142 
Gallocatechin (100 mg) isolated from PFT was methylated with 143 
dimethylsulfate (1.0 mL), K2CO3 (1.0 g) in dry acetone (30 mL) under reflux for 1 h. 144 
After removal of inorganic salts by filtration, the filtrate was concentrated and separated 145 
by silica gel chromatography with toluene containing increasing proportions of acetone 146 
(0 – 10%, 2% stepwise) to yield pentamethylate (16 mg) as colorless needles from 147 
MeOH, mp 165-166°C, [α]D22 +15.0 (c = 0.1, CHCl3). The methylate (3.0 mg) was 148 
treated with a mixture of dicyclohexylcarbodiimide (10.0 mg), 149 
4-dimethylaminopyridine (5.0 mg) and 150 
(R)-(+)-α-methoxy-α-trifluoromethylphenylacetic acid (5.0 mg) in CH2Cl2 (1.0 mL) at rt 151 
for 12 h. The resulting mixture was separated by silica gel chromatography with 152 
hexane-acetone (85:15, v/v) to give the (R)-MTPA ester (5.6 mg). The use of 153 
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(S)-(-)-α-methoxy-α-trifluoromethylphenylacetic acid gave the (S)-MTPA ester (4.5 mg). 154 
Δδ (δS-δR): H-2 (-0.059), B-ring H-2, 6 (-0.116), H-4eq (-0.076), and H-4ax (+0.127). 155 
 156 
2.6. Preparation of acetone powder 157 
The PFT (20 g) was crushed using a mechanical blender and further pulverized 158 
with a mortar and pestle. The powder was mixed with H2O (40 mL) and placed in an 159 
incubator (30°C) for 2 days. The wet powder was cooled in an ice bath, mixed with 160 
acetone (0°C, 260 mL), and gently stirred at 0-4°C for 2 h. The resulting tea leaf powder 161 
was collected by vacuum filtration, washed repeatedly with cooled acetone, and dried 162 
under reduced pressure (14.1 g). The powder was stored at -20°C. 163 
 164 
2.7. Aerobic and anaerobic treatment of tea catechins with acetone powder 165 
For aerobic treatment, the acetone powder (250 mg) was added to an aqueous 166 
solution (5 mL) of (-)-epigallocatechin (25 mg) and incubated at 30°C. After 24 h, 48 h, 167 
and 72 h, aliquots (300 μL) were taken and mixed with EtOH (700 μL). The solution 168 
was filtered through a membrane filter (0.45 μm) and analyzed by HPLC. 169 
(-)-Epigallocatechin was examined in a similar manner. For anaerobic treatment, the 170 
acetone powder (100 mg) was added to an aqueous solution (1 mL) of 171 
(-)-epigallocatechin-3-O-gallate (5 mg) and incubated at 37°C in a nitrogen atmosphere 172 
for 10 days. After addition of EtOH (1.5 mL), the mixture was filtered through a 173 
membrane filter (0.45 μm) and analyzed by HPLC. 174 
 175 
2.8. Anaerobic treatment of epigallocatechin with acetone powder 176 
In a 50 mL vial, the acetone powder (1.0 g) was mixed with an aqueous 177 
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solution (8 mL) of (-)-epigallocatechin (50 mg). The vial was placed in a vacuum 178 
desiccator and the air was completely replaced by nitrogen gas. The desiccator was 179 
placed in an incubator (35°C) for 10 days. Then the solution was mixed with 80% EtOH 180 
(22 mL) and stirred at rt for 4 h. After filtration, the filtrate was concentrated under 181 
reduced pressure and separated by Diaion HP20SS (2 cm i.d. × 20 cm) with water 182 
containing increasing proportions of MeOH (0 – 100%, 10% stepwise, each 50 mL) to 183 
yield EGC-M2 (13 mg), EGC-M3 (8.4 mg), and a fraction containing EGC-M1 (10 mg). 184 
The EGC-M2 (13 mg) was dissolved in 2% trifluoroacetic acid (0.5 ml) and applied to a 185 
Sephadex LH-20 column (1 cm i.d. × 15 cm) equilibrated with water, and eluted with 186 
MeOH to give EGC-M3 (8.2 mg). The fraction containing EGC-M1 was separated by 187 
Sephadex LH-20 column chromatography (1 cm i.d. × 15 cm) with water containing 188 
increasing proportions of MeOH (0 – 100%, 10% stepwise, each 10 mL) to afford 189 
EGC-M1 (1.0 mg), EGC-M4 (1.2 mg), and a mixture of epigallocatechin and 190 
gallocatechin (0.9 mg). EGC-M1: 1H-NMR (acetone-d6 + D2O) δ: 6.25 (2H, s), 5.91 191 
(2H, s), 3.99 (1H, m), 2.93 (1H, dd, J = 3, 14 Hz), 2.64 (1H, dd, J = 7, 14 Hz), 2.65 (1H, 192 
dd, J = 4, 14 Hz), 2.47 (1H, dd, J = 8, 14 Hz). EGC-M2: 1H-NMR (acetone-d6 + D2O) δ: 193 
6.22 (2H, s, H-2',6'), 3.71 (1H, m, H-4), 2.53 (1H, dd, J = 7, 13 Hz, H-5), 2.42 (1H, dd, 194 
J = 7, 13 Hz, H-5), 2.41, 2.29 (each 1H, m, H-2), 1.71, 1.54 (each 1H, m, H-3). 195 
EGC-M3: 1H-NMR (acetone-d6 + D2O) δ:6.29 (2H, s, H-2',6'), 4.63 (1H, br quintet, J = 196 
6 Hz, H-4), 2.79 (1H, dd, J = 6, 14 Hz, H-5), 2.66 (1H, dd, J = 7, 14 Hz, H-5), 2.44 (1H, 197 
ddd, J = 8, 9, 18 Hz, H-2), 2.33 (1H, ddd, J = 5, 98, 18 Hz, H-2), 2.22, 1.93 (each 1H, m, 198 
H-2). EGC-M4: 1H-NMR (acetone-d6 + D2O) δ:6.73 (1H, br s, H-2'), 6.71 (1H, d, J = 8 199 
Hz, H-5'), 6.54 (1H, br d, J = 8 Hz, H-6'), 4.65 (1H, br quintet, J = 6 Hz, H-4), 2.83 (1H, 200 
dd, J = 6, 14 Hz, H-5), 2.73 (1H, dd, J = 7, 14 Hz, H-5), 2.44 (1H, ddd, J = 8, 9, 18 Hz, 201 
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H-2), 2.32 (1H, ddd, J = 5, 9, 18 Hz, H-2), 2.21, 1.91 (each 1H, m, H-2). 202 
 203 
2.8. Anaerobic treatment of rutin with acetone powder 204 
Rutin (50 mg) was dissolved in H2O (20 mL) by heating. After cooling, the 205 
acetone powder (2.0 g) was added to the solution and placed in the vacuum desiccator. 206 
After the air was replaced by nitrogen gas, the desiccator was placed in the incubator 207 
(37°C) for 7 days. 80% EtOH (40 mL) was then added to the mixture and stirred at rt 208 
for 5 h. Insoluble materials were removed by filtration, and the filtrate was concentrated 209 
by rotary evaporation. The residue was separated by Diaion HP20SS (2 cm i.d. × 20 cm) 210 
with 0.1% trifluoroacetic acid containing increasing proportions of MeOH (0 – 100%, 211 
10% stepwise, each 50 mL) to yield 3,4-dihydroxyphenylacetic acid (6.7 mg) as an 212 
amorphous powder, 1H NMR (CD3OD) δ: 6.74 (2H, br s, H-2', H-6'), 6.59 (1H, d, J = 8 213 
Hz, H-5'), 2.38 (2H, s, H-2), 13C NMR (CD3OD) δ:172.9 (C-1), 145.9, 145.0 (C-3', 214 
C-4'), 127.4 (C-1'), 121.9 (C-6'), 117.5, 116.5 (C-2', C-5'), 41.3 (C-2). 215 
 216 
2.9. Anaerobic treatment of hesperidin with acetone powder 217 
Hesperidin (100 mg) was dissolved in H2O (20 mL) by heating. After cooling, 218 
the acetone powder (2.0 g) was added to the solution and placed in the vacuum 219 
desiccator. After the air was replaced by nitrogen gas, the desiccator was placed in the 220 
incubator (37°C) for 7 days. Then, the product was separated in a manner similar to that 221 
described for rutin to yield 3-(3,4-dihydroxyphenyl)propanoic acid (41.6 mg) as an 222 
amorphous powder: 1H NMR (acetone-d6) δ: 6.67 (1H, d, J = 2 Hz, H-2'), 6.63 (1H, d, J 223 
= 8 Hz, H-5'), 6.48 (1H, dd, J = 2, 8 Hz, H-6'), 2.63, 2.30 (each 2H, br t, J = 6 Hz, H-2, 224 
H-3), 13C NMR (acetone-d6) δ:179.7 (C-1), 145.0, 143.2 (C-3', C-4'), 134.6 (C-1'), 120.0 225 
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(C-6'), 116.0, 115.8 (C-2', C-5'), 39.6, 31.9 (C-2, C-3). 226 
 227 
3. Results and discussion 228 
Previously we concluded that the major constituents of the PFT produced in the Ehime 229 
prefecture are EGC-M1, EC-M, (-)-epigallocatechin (EGC), (-)-gallocatechin (GC), 230 
pyrogallol, caffeine, (-)-catechin (Cat) and (-)-epicatechin (EC) (Fig. 1). In addition, 231 
lactic acid, gallic acid, catechin-(4α→8)-epigallocatechin (Hashimoto, Nonaka, & 232 
Nishioka, 1989), 3-O-methylgallic acid, 3-O-methylpyrogallol, dihydromyricetin (Jeon, 233 
Chun, Choi, & Kwon, 2008), quercetin, and kaempferol have also been identified in 234 
PFT from the Ehime prefecture. The lactic acid was a mixture of the D and L-forms (2: 235 
3), which was determined by chiral HPLC after methylation and 236 
4-methoxybenzoylation. Configuration of (-)-catechin was confirmed by its optical 237 
rotation, and that of (-)-gallocatechin was determined by comparison of the optical 238 
rotation of the pentamethyl ether (Delle Monache, D'Albuquerque, De Andrade 239 
Chiappeta, De Mello, 1992) and application of advanced Mosher's method (Kusumi, 240 
Ohtani, Inoue, & Kakisawa, 1988). The significantly high concentration of 241 
(2S,3R)-catechins compared with that in green tea strongly suggested occurrence of 242 
epimerization at the benzylic C-2 positions of the original (2R,3R)-catechins during 243 
fermentation. Production of EGC-M1 and EC-M apparently indicated occurrence of 244 
reductive cleavage of the catechin C-rings. Furthermore, the absence of galloylated 245 
catechin and the presence of a large amount of pyrogallol suggested occurrence of 246 
hydrolysis of the galloyl esters and subsequent decarboxylation of gallic acid. 247 
 To confirm the chemical conversions of tea catechins, we prepared an acetone 248 
powder of the PFT and examined its ability to metabolize epigallocatechin-3-O-gallate 249 
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(EGCg), which is the most abundant tea catechin in fresh tea leaf. In the PFT production 250 
at Ehime prefecture, the heated tea leaves are first fermented under aerobic conditions; 251 
therefore, EGCg was first treated with the acetone powder under aerobic conditions at 252 
30°C, and the products were analyzed by reversed-phase HPLC (Fig. 2A). EGCg was 253 
first hydrolyzed to give epigallocatechin (EGC) and gallic acid. This is probably owing 254 
to the activity of tannase, which is typically isolated from Aspergillus sp (Tamura et al., 255 
1994; Sharma, Bhat, & Dawra, 1999; Murugan, Saravanababu, & Arunachalam, 2007). 256 
Further aerobic fermentation for 2 days yielded pyrogallol and gallocatechin (GC). 257 
Production of pyrogallol from gallic acid was confirmed by treatment of gallic acid with 258 
the acetone powder under similar conditions. Production of GC from EGC was slower 259 
than hydrolysis (Fig. 2B) and production of EGC-M1 was not observed under aerobic 260 
conditions. 261 
 After the aerobic fermentation process during the PFT production, the leaves 262 
next undergo anaerobic fermentation. Under aerobic conditions, EGCg was converted to 263 
EGC; therefore, degradation of EGC under anaerobic conditions was examined (Fig. 4). 264 
Treatment of EGC with PFT acetone powder in a nitrogen atmosphere at 35°C for 10 265 
days afforded EGC-M1 and several unknown products. Separation by column 266 
chromatography using Diaion HP20SS and Sephadex LH-20 afforded EGC-M2, 267 
EGC-M3 and EGC-M4 along with a mixture of EGC and GC. Comparison of the 1H 268 
NMR spectra revealed that the products were 269 
(4R)-5-(3,4,5-trihydroxyphenyl)-4-hydroxypentanoic acid, 270 
(4R)-5-(3,4,5-trihydroxyphenyl)-γ-valerolactone (Takagaki, et al., 2010; Kohri, 271 
Matsumoto, Yamakawa, Suzuki, Nanjo, Hara, & Oku, 2001), and 272 
(4R)-5-(3,4-dihydroxyphenyl)-γ-valerolactone (Li, Lee, Sheng, Meng, Prabhu, Winnik, 273 
13 
 
Huang, Chung, Yan, Ho, & Yang, 2000), respectively (Fig. 5). The structure of EGC-M1 274 
was also confirmed by treatment of EGC-M1 with trifluoroacetic acid which afforded 275 
EGC-M2. Although only EGC-M1 was isolated from the PFT products, the results 276 
indicated that the PFT acetone powder is capable of producing EGC-M2, M3 and M4, 277 
as the intestinal bacteria degrade EGCg (Takagaki, et al., 2010; Li, et al., 2000). Direct 278 
anaerobic treatment of EGCg with PFT acetone powder afforded mainly EGC and GC, 279 
and small peaks attributable to EGC-M1 and M2 were also detected upon HPLC 280 
analysis (Fig. 3). However, peaks of gallic acid and pyrogallol were not detected. 281 
Analysis of the total peak area of the HPLC suggested that a large part of the initial 282 
EGCg decomposed to uncharacterized products, which were not detected under the 283 
present HPLC conditions. 284 
 In addition to the tea catechins, reaction of rutin and hesperidin, which were 285 
selected as the important flavonoids in vegetables and fruits, were examined. Treatment 286 
of the flavonoids with the PFT acetone powder under anaerobic conditions afforded 287 
3,4-dihydroxyphenylacetic acid (Booth, Murray, Jones, & DeEds, 1956) and 288 
3-(3,4-dihydroxyphenyl)propanoic acid (Honohan, Hale, Brown, & Wingard, 1976), 289 
respectively (Fig. 6). The degradation products were the same as those observed from 290 
bacterial metabolism in the mammalian intestine. The results suggested that the PFT 291 
acetone powder has the ability to metabolize the flavonoids, though the metabolites 292 
were not detected from the original PFT. 293 
 294 
 295 
4. Conclusions 296 
In this study, we showed that the acetone powder of Japanese PFT has the 297 
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ability to produce compounds identical to the metabolites of polyphenols produced by 298 
mammalian intestinal bacteria, though there are some differences between the 299 
constituents of the original tea and the products obtained in our experiments. As 300 
mentioned previously, the PFT of Ehime prefecture, which was used in this study, is 301 
produced by a combination of aerobic and anaerobic fermentation. In the PFT, galloyl 302 
esters are hydrolyzed and pyrogallol was produced from gallic acid. In contrast, lack of 303 
an aerobic fermentation step in the production in the PFT from Tokushima prefecture is 304 
reflected by the presence of catechin galloyl esters and the absence of pyrogallol. The 305 
acetone powder produced from the Tokushima PFT did not show activity. It is well 306 
known that pyrogallol and pyrogallol-type tea catechins, EGC and EGCg, have strong 307 
antioxidative activity; however, the reactivity is reflected by its instability especially 308 
under neutral and alkaline conditions. The oxidation-sensitive polyphenols are probably 309 
stabilized by lactic acid which is produced by the anaerobic fermentation and is 310 
responsible for the sour taste of the PFT. Lactic acid keeps the pH low and suppresses 311 
the dissociation of the phenolic hydroxyl groups of the pyrogallol rings. The Japanese 312 
PFT produced by anaerobic fermentation has been used for drinking in a local area of 313 
Shikoku Island of Japan, and it is very interesting to note that some related tea products 314 
are also known in Myanmar (lepet-so), Thailand (miang), and China (zhu-tong-cha) 315 
(Namba, Nyein, Win, & Miyagawa, 1999; Tanasupawat, Pakdeeto, Thawai, Yukphan, & 316 
Okada, 2007). It is well recognized that tea catechins have various health benefits; 317 
however, it is also known that the direct absorption of catechins from the digestive tract 318 
is not very high (Miyazawa, 2000; Zhu, Chen, & Li, 2000). Therefore, absorption of gut 319 
bacterial metabolites with smaller molecular sizes is important, and this may partly be 320 
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Figure Captions 405 
Fig. 1 HPLC profile of 60% EtOH extract of Japanese post-fermented tea. 406 
 Detection at 220 nm, Caf: caffeine, EC: epicatechin, EC-M: 407 
(2S)-1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol, EGC: 408 
epigallocatechin, EGC-M1: (2S)-1-(3',4',5'-trihydroxyphenyl)-3- 409 
(2'',4'',6''-trihydroxyphenyl)-propan-2-ol, EGCg: epigallocatechin-3-O-gallate, Fl: 410 
quercetin monoglycoside, GA: gallic acid, GC: gallocatechin, K: kaempferol, PG: 411 
pyrogallol, Q: quercetin. 412 
 413 
Fig. 2 HPLC profiles of aerobic treatment of epigallocatechin-3-O-gallate (A) and 414 
epigallocatechin (B) with acetone powder. 415 
 416 
Fig. 3 HPLC profile of products obtained by anaerobic treatment of 417 
epigallocatechin-3-O-gallate. 418 
 EGC: epigallocatechin, EGCg: epigallocatechin-3-O-gallate, GC: gallocatechin, 419 
EGC-M1: (2S)-1-(3',4',5'-trihydroxyphenyl)-3- (2'',4'',6''-trihydroxyphenyl)-propan-2-ol, 420 
EGC-M2: (4R)-5-(3,4,5-trihydroxyphenyl)-4-hydroxypentanoic acid. 421 
 422 
 423 
Fig. 4 HPLC profile of products obtained by anaerobic treatment of epigallocatechin.  424 
 EGC-M1: (2S)-1-(3',4',5'-trihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol, 425 
EGC-M2: (4R)-5-(3,4,5-trihydroxyphenyl)-4-hydroxypentanoic acid, EGC-M3: 426 





Fig. 5 Degradation of epigallocatechin-3-O-gallate on treatment with the Japanese 430 
post-fermented tea acetone powder. 431 
 432 
Fig. 6 Degradation of rutin and hesperidin on treatment with Japanese 433 
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